학술논문

Early Release - Guaroa Virus and Plasmodium vivax Co-Infections, Peruvian Amazon - Volume 26, Number 4—April 2020 - Emerging Infectious Diseases journal - CDC
Document Type
article
Source
Emerging Infectious Diseases. 26(4)
Subject
Medical Microbiology
Biomedical and Clinical Sciences
Clinical Sciences
Rare Diseases
Malaria
Emerging Infectious Diseases
Infectious Diseases
Vector-Borne Diseases
Aetiology
2.2 Factors relating to the physical environment
Infection
Good Health and Well Being
Coinfection
Humans
Malaria
Vivax
Orthobunyavirus
Peru
Plasmodium vivax
Guaroa virus
Peruvian Amazon
co-infection
malaria
parasites
vector-borne infections
viruses
Public Health and Health Services
Microbiology
Clinical sciences
Epidemiology
Health services and systems
Language
Abstract
During April-June 2014 in a malaria-endemic rural community close to the city of Iquitos in Peru, we detected evidence of Guaroa virus (GROV) infection in 14 febrile persons, of whom 6 also had evidence of Plasmodium vivax malaria. Cases were discovered through a long-term febrile illness surveillance network at local participating health facilities. GROV cases were identified by using a combination of seroconversion and virus isolation, and malaria was diagnosed by thick smear and PCR. GROV mono-infections manifested as nonspecific febrile illness and were clinically indistinguishable from GROV and P. vivax co-infections. This cluster of cases highlights the potential for GROV transmission in the rural Peruvian Amazon, particularly in areas where malaria is endemic. Further study of similar areas of the Amazon may provide insights into the extent of GROV transmission in the Amazon basin.